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A NewWorld Health Era
Ariel Pablos-Méndez,a Mario C Raviglioneb
Unprecedented economic progress and demands for social protection have engendered an economic transition
in health in many low- and middle-income countries, characterized by major increases in domestic health
spending and growing national autonomy. At the global level, development assistance is refocusing on fragile
states, the poorest communities, and cooperation on global public goods like health security, technical norms,
and innovation. Intergovernmental organizations like WHO need the wherewithal and support to provide
leadership and to properly advance this new world health era.
Between 2010 and 2015, development assistance forhealth (DAH) reached over US$30 billion a year,1
and the Millennium Development Goals (MDGs)2
helped drive unprecedented gains in development and
health equity.3 While those accomplishments are cause
for celebration,4 DAH budgets have tightened1 as the
world confronts new health challenges, and the global
health community is worried about human rights rever-
sals by recently elected populist governments.5 Health fi-
nancing at the country level looks more promising and
could be the basis for a new world health era.
AN ECONOMIC TRANSITION IN HEALTH
After centuries of flat incomes per capita, the world has
experienced a 20-fold increase in gross domestic product
(GDP) during the last 50 years.6,7 The majority of coun-
tries that were considered low-income in 1990, includ-
ing Bolivia, Bangladesh, and the Republic of Congo,
have moved to lower-middle or middle-income status.8
Health spending is very closely correlated with GDP
and it accounts for an expanding fraction of any growing
economy.9 While that is often a fiscal and political head-
ache for richer countries, for a growing number of
lower-income countries the increase in health resources
has the potential to cover the average cost per capita of
essential lifesaving commodities and services.9
As DAH plateaued in recent years,1 many low-
income countries saw total health spending grow at
10% per year (based on data from National Health
Accounts compiled by USAID in 2015). Public and pri-
vate domestic resources now dwarf DAH (Figure 1).
The growth of health spending, however, follows a surge
in the demand for health services that is often met by
unregulated private services paid out-of-pocket, an inef-
ficient and regressive form of health financing.11 This
transition is linked to the economics of countries at dif-
ferent stages of development. Thus, these changes have
already occurred in several countries and may not be
complete in others by 2030.
A HISTORICAL PENDULUM IN THE
POLITICAL ECONOMY
Political economy is the branch of social science that
studies the relationships between individuals and society
and between markets and the state.12 The liberal forces
galvanized by the Enlightenment, the 18th century phil-
osophical movement in Europe that promoted freedom,
fraternity, solidarity, and equality, have brought un-
precedented well-being to our civilization,13 but pro-
gress has not been linear. Periodic structural shifts in
the political economy, whether arising from global crises
or national elections, bring new challenges and opportu-
nities and change theways in which the health agenda is
advanced.
AfterWorldWar II, with the end of European coloni-
alism, what was known as geographic or "tropical
medicine" became firmly established as "international
health," with newly created international agencies and
new and assertive nations committed to primary health
care (Figure 2).14 The World Health Organization
(WHO) was the unquestionable leader of the period,
but its uniqueness started being challenged in the early
1990s.15–18
At that time, after the collapse of the Soviet Union,
theWashington Consensus—the set ofmarket economic
ideas supported by the International Monetary Fund
and the World Bank—downplayed national govern-
ment and promoted neoliberal policies, i.e., a strong
market-based approach to globalization, decentraliza-
tion, and privatization.19 New philanthropy and the
AIDS movement were additional ingredients of what
became "global health."20 WHO's influence waned21,22
amidst a plethora of new public-private partnerships
advancing donor-supported initiatives against AIDS,
tuberculosis, malaria, and vaccine-preventable dis-
eases.14,23 While some experts worried about open-
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source anarchy and undue influence,24 these
global partnerships contributed to achieving sev-
eral MDGs.
We are at a new inflexion point. The Great
Recession of 2008 caused a reduction in global
GDP and global trade for the first time in half a
century.25 While markets have recovered since,
their failure caused ongoing social pain and
revealed severe inequalities,26 leading to eco-
nomic insecurity and growing political demand
for social protection and popular rejection of
globalization.5,27
National governments are reasserting them-
selves, in extreme cases with protectionism and
xenophobia.28 Countries that responded to the
crisis with fiscal austerity have faced a wave of
antiestablishment, ethnopopulist elections not
seen since the 1930s.29 This creates many domes-
tic problems of its own and pushes back against
the international cooperation and altruism that
characterized the golden era of global health. In
the long run, populism is no substitute for sound
governance and it carries risks.30 Good technical
and political leadership is needed to address the
underlying economic inequalities responsible for
the social turmoil seen in many countries.
A NEWWORLD HEALTH ERA?
Economic growth and increasing health spending
in many "developing" countries, along with stag-
nant DAH and a wave of populist policies, pave
the way for a number of profound changes in our
field (Table). At the national level, there will be
more country ownership and domestic resource
mobilization (DRM), with an increasingly feasible
possibility of achieving universal health coverage
(UHC). At the global level, the power of DAH is
diluted and likely to refocus on fragile states and
global public goods with benefits to all countries
(see below). As a result, member-state organiza-
tions like WHO and the World Bank, in coordina-
tion with other influential public and private
actors, have new opportunities to address existing
and emerging health challenges.31 Many existing
organizations at the global and national level will
adjust the role they play and how they fund their
work in this new world health era.
Domestic Resource Mobilization
With emerging economies growing, the Third
International Conference on Financing for
Development, held in Addis Ababa, Ethiopia,
FIGURE 1. Financing Trends in Developing Countries, 2000–2014 (in US$, billions, 2013 prices)
Note: Public domestic finance is defined as total government revenue. Gross-fixed capital formation by the private sector was used as an indicator for private
domestic finance. Private international finance is the sum of foreign direct investment, portfolio equity and bonds, commercial banking and other lending, and
personal remittances. Public international finance equals the total official flows (official development assistance and other official flows).
Source: United Nations Research Institute for Social Development (2016).
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positioned DRM at the heart of the post-
2015 agenda.32 The World Bank estimates that
simply bringing laggards to the median govern-
ment revenue level by increasing tax ratios to
the median 23% of GDP in low- and middle-
income countries would add US$26 billion each
year for public expenditure in health.33 In
addition, increasing the government budget allo-
cation for health to just the median level of
10% would generate an extra $50 billion each
year.33 Tobacco taxes can contribute to general
taxation and also reduce one of the main drivers
for chronic diseases. Additional DRM possibilities
include leveraging concessionary loans from
development banks (e.g. the Global Financing
Facility),34 innovative financing (e.g., social
impact bonds, loan guarantees),35 and shaping
responsible markets.36 Countries like Ghana,
Ethiopia, and Rwanda have shown it is possible
to increase health budgets significantly.
Universal Health Coverage
As shown in Figure 1, health spending is rising
and will likely continue to do so as GDP expands.
In the absence of government policy on public or
private insurance, health spending is often paid
out-of-pocket by individuals, which sends mil-
lions of families back into poverty.37,38 Such
expenditures account for 50% of total health
spending in most African countries and up to
80% in large South Asian nations—versus less
than 20% in most countries of the Organisation
for Economic Co-operation and Development
(OECD).11 In response to this growing challenge,
UHC is becoming the organizing principle for
health systems everywhere.39,40
UHC means 3 things: (1) access for all to
(2) appropriate health services (at a minimum,
health promotion and primary care, with addi-
tional services depending on local epidemiology
and economics), and (3) without financial hard-
ship (financial hardship is defined as 25% or
more of total household expenditures spent on
out-of-pocket health expenditures).37 UHC is not
about donors buying health insurance but about
national governments organizing health financing
in equitable, prepaid risk pools.32 The services cov-
ered under UHC should be not only curative but
also public health and preventive, like immuniza-
tion, nutrition, family planning, and road safety
interventions. Indeed a major challenge is to
prioritize such services in the face of huge
demand for expensive tertiary care for urban
elites. According to the International Labour
Organization, over 60 countries have achieved
UHC and several more are halfway in their
decades-long reforms (Figure 3).41 Many coun-
tries, especially in Africa, are asking for technical
assistance to reorient their health sector toward
UHC.
A global movement toward the progressive
realization of UHC is unfolding.37,42 Following
theWorld Health Report 2010,37 the United Nations
(UN) General Assembly passed a resolution sup-
porting UHC,43 which is now enshrined in the
Sustainable Development Goal (SDG) targets for
2030.44 The G7 and the G20—the international
FIGURE 2. A New Chapter in International Health History
Note: This graph is only a didactic tool; historical periods often overlap and vary from one country or region to another, and many
components of one period carry over to future ones.
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summits where leaders from theworld's advanced
and emerging economies meet to discuss critical
global issues—support UHC, and a UHC Alliance
has been born to foster and track progress to
2030. At the December 2017 Universal Health
Coverage Forum in Tokyo, Japan's Prime
Minister Shinzo Abe pledged US$2.9 billion
for UHC while UN Secretary-General António
Guterres announced UHC will be the subject of a
high-level meeting at the UN General Assembly
in 2019,45 giving impetus to WHO's goal of
expanding health coverage to an additional 1 bil-
lion people in 5 years.37
Development Assistance for Health
This new world health era will be driven by
DRM rather than DAH and that will affect
the role played by governments, industry, and
international organizations.46 Diluted by domestic
growth, DAH today accounts for less than 20% of
the total health spending even in Africa47 and is
shrinking in most recipient countries. It is already
below 1% in middle-income countries like India.
Donors are graduating successful countries from
external assistance,48 with the goal of concentrat-
ing DAH in the poorest nations by 2030.40 These
international donors also have a window of op-
portunity to support the transformation of health
systems toward prioritizing prevention and pri-
mary care in UHC; most DAH programs are mov-
ing from service provision to capacity building
and technical assistance.48
Global Public Goods
In this context, DAH should shift progressively to
support global public goods49 like global health
TABLE. Changes in the Health Field, 1960s to Present Day
International Health Global Health New World Health
Period 1960s to 1990s 1990s to circa 2015 2008 to Present
Geopolitical origins End of European Colonialism
with new voting members in a
newly formed UN
End of the Cold War (and the Soviet
Union), freer trade, Internet, and
AIDS
Financial markets crash, OECD
recession, and emergent developing
economies
Political economy tone Cold War with East-West
divide
"Government is the problem," mar-
kets and civil society the solution
Reassertion of nation-state and
demands for social protection
Construction of health WHO holistic definition and
social construction of health
Simultaneously, human rights and
reductionist technology
Multisectoral, social determinants,
and universalism
Predominant approach Primary health care, "Health
for All," and solidarity as uni-
versal principles and
movements
Top-down programs and PPPs to fight
key diseases of poverty in developing
countries
Grand convergence between North
and South, progressive realization
of UHC and global health security
International cooperation Colored by foreign affairs
(East-West competition, with
exceptions like smallpox
eradication)
Explosion of NGOs, PPPs, and new
philanthropy tackling the MDGs in
poor countries
Assertive but interdependent nation-
states sign up to the universal SDGs
Development assistance for health Newly created UN agencies
like WHO and bilateral
donors like USAID
Billion-dollar platforms (Gavi, The
Global Fund, PEPFAR), Bill & Melinda
Gates Foundation a major player,
golden era of DAH
DAH stagnation, domestic resource
mobilization, and graduation from
assistance (except fragile states)
Governance WHO takes center stage in the
UN architecture
"Open source anarchy" (WHO's
authority diluted)
Sovereign states reasserted;
opportunity for WHO
Private sector Essentially proscribed from
UN settings and agenda
Rise in prominence both through PPPs
and philanthropy, IT enables global
communications
Half of the health sector provision
and growing markets in emerging
economies
Civil society and community role Empowerment of communities
after Alma-Ata Declaration of
1978
Growing activism, especially linked
with HIV/AIDS
National NGOs very important
despite closing space in some
countries
Abbreviations: DAH, development assistance for health; IT, information technology; MDGs, Millennium Development Goals; OECD, Organisation for Economic
Co-operation and Development; PEPFAR, U.S. President's Emergency Plan for AIDS Relief; PPPs, public-private partnerships; SDGs, Sustainable Development
Goals; UHC, universal health coverage; UN, United Nations; USAID, United States Agency for International Development; WHO, World Health Organization.
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security, international norms, pooled procure-
ment, and research and development (particularly
on diseases of poverty). While the Ebola epidemic
galvanized donors to improve global health secu-
rity,50–52 the other areas mentioned deserve equal
and sustained attention. Funding global public
goods makes sense as DAH dollars in countries
decline or are diluted by DRM, and given their
broader benefits including to the citizens of donor
countries. Led by BRICS countries (Brazil, Russia,
India, China, and South Africa), these and many
other "emerging" economies are also contributing
valuable research and development and other
innovations in South-South collaboration.53
The MDGs helped generate increased political
support and funding against child and maternal
mortality, HIV/AIDS, tuberculosis, and malaria.
The end result was major reductions in mortality
and suffering from these conditions.2 However,
chronic noncommunicable diseases (NCDs) are a
neglected area in global health that is ripe for crea-
tive action. NCDs are now the leading cause of
death worldwide,54 and the epidemiologic transi-
tion is proceeding rapidly in Africa.55 Yet invest-
ments and effective solutions have lagged.1,56
UHC, backed by targeted DAH, offers an opportu-
nity to tackle NCDs with multisectoral initiatives
as predicated by the SDG framework.57
The Private Sector and Civil Society
During the 1970s, the private sector was nearly
absent from public health circles, though it was al-
ready playing a growing role in the provision of
medicines and clinical services. At the turn of
themillennium,many public-private partnerships
FIGURE 3. Universal Health Coveragea: The New Frontier for Global Health
a The graph assesses the proportion of the population affiliated with national health insurance or social, private, or micro- insurance schemes.
Source: This graph was first published in Garret (2009)39 and later updated in the International Labour Organization (2017).
41
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(PPPs), like Gavi or the Global Alliance for TB
Drug Development, were created to address mar-
ket failures in the development and supply of
drugs and vaccines. The change brought energy,
creativity, and progress for orphan drugs and the
MDGs.
PPPs 2.0 will be less top-down and more
engaged in local markets and political economy,
where the private sector accounts for half of total
health expenditures.1 Private practitioners, formal
or informal, already play a prominent role in serv-
ice provision.58 Governments will need stronger
stewardship capacity to regulate mixed health sys-
tems59 and shape markets to ensure quality and
equity.31 As countries move toward UHC, govern-
ments will need to prioritize public financing for
primary health care and population-based pre-
vention, besides provision of curative services.60
Civil society, uniting forces with public
health officials and political leaders, dramatically
changed the response to HIV/AIDS, making it a
top priority at all levels and driving unprecedented
growth of DAH for lifesaving interventions.61 Civil
society organizations will continue to play a criti-
cal role even as some authoritarian governments
try to close the space for their work. If anything,
the moral and innovative voice of NGOs, commu-
nity organizations, and other civil society actors is
a public good that will further grow in importance
to guide multisectoral policy for UHC and to hold
politicians accountable to the citizenry.62
While health is only one of 17 SDGs, the
principle of partnership and new approaches to
multisectoral collaboration will remain key in
this new era. Interdependence requires closer
cooperation and common aims among relevant
UN agencies, development banks, professional
organizations and, yes, the private sector. WHO
governing bodies are exploring more inclusive
engagement of non-state actors without compro-
mising their ethics and neutrality.63
The World Health Organization
As the premier UN agency for health,WHO figures
prominently in historical analyses of international
health.14,22 With greater emphasis on domestic
resources, assertive member states, and the cen-
trality of national health systems, this new era
offers an opportunity to better define the role of
intergovernmental organizations such as WHO
and the World Bank.64 That is a challenge for the
recently elected WHO Director-General65 given
the complexity the international arena accrued in
the previous era18 and the internal organizational
challenges posed by decentralized management
and constrained budgets66 relative to expecta-
tions. Tellingly, the new Director-General is from
Africa and was elected for the first time by all
member states, giving him, in principle, unprece-
dented political capital to forge ahead with his
priorities, including UHC and global health secu-
rity. Unlike previous eras, this new agenda has
been forged and embraced by the World Bank
Group as central to human capital and economic
development.44
To succeed in a new world health era and
deliver on the SDG agenda, WHO will need to act
on several fronts and focus on its comparative
advantages. Firstly, while technical assistance to
countries and strategic leadership may not be
unique to WHO, ensuring their adequate and
neutral provision to member states is key to its
mission. WHO needs to be able to swiftly declare
public health emergencies of international con-
cern and help improve the world's capacity to
detect and respond to pandemic threats, including
adherence to international health regulations
and new ideas like the Coalition for Epidemic
Preparedness Innovations,67 the Pandemic Emer-
gency Financing Facility,51 and the Global Virome
Project.68 WHOwill have a crucial role in rethink-
ing and modernizing surveillance systems and
data analytics platforms, as well as the standards,
prequalification, and procurement of essential
drugs and vaccines in collaboration with the pri-
vate sector.
As with the Framework Convention on
Tobacco Control and The World Health Report on
UHC,37 WHO will be expected to provide country
guidance for future-oriented health systems and
policies. Together with theWorld Bank and devel-
opment partners, WHO should advocate for
increasing DAH for the poorest countries while
advising better-off members states to prepare for
successful graduation from DAH through hybrid
mechanisms like the Global Fund and the Global
Financing Facility.34 Finally, WHO should expand
the reach and quality of its advocacy and strategic
communication capacity to ensure that global
guidelines are clearly understood by all relevant
audiences.
Internally,WHOneeds to address several chal-
lenges if it is to thrive in this newworld health era.
It needs to define better the roles and responsibil-
ities of its headquarters, regional, and country offi-
ces. Instead of relying only on its staff, WHO could
harness today's global brain trust of experts and
centers of excellence, and it should streamline the
appointment of senior staff based on high-level
PPPs 2.0 will be
less top-down and
more engaged in
local markets and
political economy.
WHOneeds to
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expertise and competence rather than on geopol-
itical considerations. A major challenge compro-
mising the effectiveness of WHO and threatening
its independence is its budget,66 which is lower
than the revenues of any large hospital in New
York City—and three-quarters of theWHObudget
comes from voluntary contributions. Member
states' decisions to cut or increase assessed contri-
butions will be pivotal. Finally, WHO needs to
work well with the World Bank and related insti-
tutions, which can play a constructive role in fi-
nancing health and development.
CONCLUSIONS
The priorities and approaches used in interna-
tional health have evolved with epidemiological
transitions and technological innovations. But
the field has also been shaped by unprecedented
economic development and a historical pendulum
in the role of government in social well-being.
Like the Soviet Union collapse in 1991, the Great
Recession of 2008 triggered one such shift in the
political economy between government and
market.
Global health is moving past its stage of devel-
opment assistance to a new era of country owner-
ship and global cooperation.69 At the national
level, the economic transition of health and grow-
ing political demands for social protection create
conditions favorable for domestic resourcemobili-
zation and universal health coverage with new
forms of private-sector engagement. At the global
level, development assistance is refocused on
fragile states, the poorest communities, and global
public goods like health security, normativity, and
innovation.
National health systems will be the center of
gravity of a new world health era, and the evolv-
ing developments discussed in this article will call
for adjustments in the fluid architecture of inter-
national actors and the relations within and
between nation-states. This new era brings oppor-
tunities (e.g., UHC) and challenges (e.g., growing
inequalities) and new ways of financing health.
Leaders at all levels should understand and capi-
talize on this historical moment and avoid political
miscalculations like those that undermined the vi-
sionary primary health care movement 40 years
ago.15,70
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